"Our third quarter results reflect the continued progress in navigating the evolving office market. We are pleased with the NOI of our current portfolio, including the model homes and solid occupancy rates. We remain confident in our portfolio's ability to generate positive cash flow, while the Company continues to reduce G&A expenses," said
The Quarter Ended
Net loss attributable to the Company's common stockholders for the three months ended
• | Total revenues were approximately | |
• | Rental operating costs totaled approximately | |
• | G&A expenses for the three months ended | |
• | On | |
• | We review the carrying value of each of our real estate properties regularly to determine if circumstances indicate an impairment in the carrying value of these investments exists. During the three months ended | |
• | Interest expense, including amortization of deferred finance charges, was approximately |
FFO (non-GAAP) totaled approximately (
We believe Core FFO (non-GAAP) provides a useful metric in comparing operations between reporting periods and in assessing the sustainability of our ongoing operating performance. Core FFO decreased by about
Acquisitions during the nine months ended
| • | The Company did not acquire any model homes or commercial properties. |
Dispositions during the nine months ended
| • | On | |
| • | On | |
| • | The Company sold 14 model homes for approximately |
Segment Income during the three months ended
The following tables compare the Company's segment activity and NOI and adjusted NOI for Model Home income to its results of operations and financial position as of and for the three months ended
The following tables compare the Company's segment activity to its results of operations and financial position as of and for the three months ended
| For the Three Months Ended | ||||||||||||||||||||
| Retail | Office/Industrial | Corporate and Other | Total | |||||||||||||||||
Rental revenue | $ | 93,574 | $ | 1,802,349 | $ | 762,038 | $ | - | $ | 2,657,961 | ||||||||||
Recovery revenue | - | 281,526 | - | - | 281,526 | |||||||||||||||
Other operating revenue | - | 40,223 | 290 | 73 | 40,586 | |||||||||||||||
Total revenues | 93,574 | 2,124,098 | 762,328 | 73 | 2,980,073 | |||||||||||||||
Rental operating costs | 4,777 | 1,096,614 | 54,859 | (82,166 | ) | 1,074,084 | ||||||||||||||
Net Operating Income (NOI) | 88,797 | 1,027,484 | 707,469 | 82,239 | 1,905,989 | |||||||||||||||
Loss on Sale - | - | - | (100,924 | ) | - | (100,924 | ) | |||||||||||||
Impairment of | - | - | (112,436 | ) | - | (112,436 | ) | |||||||||||||
Adjusted NOI | $ | 88,797 | $ | 1,027,484 | $ | 494,109 | $ | 82,239 | $ | 1,692,629 | ||||||||||
The CODM reviews on a regular basis the GAAP performance of each segment, including the significant segment expenses reported for GAAP shown in the table below. Our significant segment expenses include consolidated expense categories presented in our consolidated statements of operations, as well as rental operating costs. This information is provided to the CODM and factors into the CODM's decision making for company-wide strategy. The following tables compare the Company's segment activity to its results of GAAP operations and financial position as of and for the three months ended
| For the Three Months Ended | ||||||||||||||||||||
| Retail | Office/Industrial | Corporate and Other | Total | |||||||||||||||||
Revenues: | ||||||||||||||||||||
Rental income | $ | 93,574 | $ | 2,083,875 | $ | 762,038 | $ | - | $ | 2,939,487 | ||||||||||
Fees and other income | - | 40,223 | 290 | 73 | 40,586 | |||||||||||||||
Total revenue | 93,574 | 2,124,098 | 762,328 | 73 | 2,980,073 | |||||||||||||||
Costs and expenses: | ||||||||||||||||||||
Rental operating costs | 4,777 | 1,096,614 | 54,859 | (82,166 | ) | 1,074,084 | ||||||||||||||
General and administrative | - | 191 | 180,374 | 1,078,820 | 1,259,385 | |||||||||||||||
Depreciation and amortization | 22,928 | 695,400 | 165,870 | 473 | 884,671 | |||||||||||||||
Impairment of goodwill and real estate assets | - | - | 112,437 | - | 112,437 | |||||||||||||||
Total costs and expenses | 27,705 | 1,792,205 | 513,540 | 997,127 | 3,330,577 | |||||||||||||||
Other income (expense): | ||||||||||||||||||||
Interest expense - mortgage notes | (38,930 | ) | (679,256 | ) | (417,927 | ) | (1,342 | ) | (1,137,455 | ) | ||||||||||
Interest and other income, net | - | - | 2 | 5,256 | 5,258 | |||||||||||||||
Net loss in Conduit Pharmaceuticals marketable securities (see footnote 9) | - | - | - | (3,261 | ) | (3,261 | ) | |||||||||||||
Loss on sales of real estate, net | - | - | (100,924 | ) | - | (100,924 | ) | |||||||||||||
Gain on extinguishment of debt | - | 1,007,432 | - | - | 1,007,432 | |||||||||||||||
Income tax (expense) benefit | - | - | 54,217 | - | 54,217 | |||||||||||||||
Total other income (expense), net | (38,930 | ) | 328,176 | (464,632 | ) | 653 | (174,733 | ) | ||||||||||||
Net income (loss) | 26,939 | 660,069 | (215,844 | ) | (996,401 | ) | (525,237 | ) | ||||||||||||
Less: Income attributable to noncontrolling interests | - | (2,919 | ) | (2,493 | ) | - | (5,412 | ) | ||||||||||||
Net income (loss) attributable to | $ | 26,939 | $ | 657,150 | $ | (218,337 | ) | $ | (996,401 | ) | $ | (530,649 | ) | |||||||

Subsequent Events:
As previously disclosed, the Company's offer to exchange shares of its Series D Preferred Stock for shares of its Common Stock (the "Exchange Offer") commenced on
About Presidio Property Trust
Presidio is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located primarily in the sun belt states. Presidio's office, industrial, and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California. For more information on Presidio, please visit Presidio's website at https://www.PresidioPT.com.
Definitions
Non-GAAP Financial Measures
Funds from Operations ("FFO") - The Company evaluates performance based on Funds From Operations, which we refer to as FFO, as management believes that FFO is a useful supplemental measure of operating performance. The[AP5.1] Company defines FFO as net income or loss (computed in accordance with GAAP), excluding gains (or losses) from sales of property, hedge ineffectiveness, acquisition costs of newly acquired properties that are not capitalized and lease acquisition costs that are not capitalized plus depreciation and amortization, including amortization of acquired above and below market lease intangibles and impairment charges on properties or investments in non-consolidated REITs, and after adjustments to exclude equity in income or losses from, and, to include the proportionate share of FFO from, non-consolidated REITs.
However, because FFO excludes depreciation and amortization as well as the changes in the value of the Company's properties that result from use or market conditions, each of which have real economic effects and could materially impact the Company's results from operations, the utility of FFO as a measure of the Company's performance is limited. In addition, other REITs may not calculate FFO in accordance with the NAREIT definition as the Company does, and, accordingly, the Company's FFO may not be comparable to other REITs' FFO. Accordingly, FFO should be considered only as a supplement to net income as a measure of the Company's performance.
Core Funds from Operations ("Core FFO") - We calculate Core FFO by using FFO as defined by NAREIT and adjusting for certain other non-core items. We exclude from our Core FFO calculation acquisition costs, loss on early extinguishment of debt, changes in the fair value of the earn-out, changes in fair value of contingent consideration, non-cash warrant dividends, other non-recurring expenses, and the amortization of stock-based compensation.
We believe Core FFO provides a useful metric in comparing operations between reporting periods and in assessing the sustainability of our ongoing operating performance. Other equity REITs may calculate Core FFO differently or not at all, and, accordingly, the Company's Core FFO may not be comparable to such other REITs' Core FFO.
Net Operating Income ("NOI") and Adjusted NOI for Model Homes - We calculate NOI as rental and other property revenues less property operating expenses as shown on our statement of operations. Operating expenses do not include depreciation and amortization, interest expense, corporate general and administrative expenses, acquisition costs, gains or losses on asset sales, impairment charges, or other non-property-specific items. Adjusted NOI for Model Home income takes NOI, plus or minus gain or loss on sale of model homes during the period, less any model home impairments taken during the period.
Cautionary Note Regarding Forward-Looking Statements
This press release contains statements that are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and other federal securities laws. Forward-looking statements are statements that are not historical, including statements regarding management's intentions, beliefs, expectations, representations, plans or predictions of the future, and are typically identified by such words as "believe," "expect," "anticipate," "intend," "estimate," "may," "will," "should" and "could." Because such statements include risks, uncertainties and contingencies, actual results may differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon the Company's present expectations, but these statements are not guaranteed to occur. Except as required by law, the Company disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, for new information, data or methods, future events or other changes. Investors should not place undue reliance upon forward-looking statements. For further discussion of the factors that could affect outcomes, please refer to the "Risk Factors" section of the Company's documents filed with the SEC, copies of which are available on the SEC's website, www.sec.gov.
Investor Relations Contact:
Presidio Property Trust, Inc.
Investor Relations
IR@presidiopt.com
Telephone: (760) 471-8536
Presidio Property Trust, Inc. and Subsidiaries
Consolidated Balance Sheets
| 2026 | 2025 | |||||||
| (unaudited) | ||||||||
| ASSETS | ||||||||
| Real estate assets and lease intangibles: | ||||||||
Land | $ | 12,507,157 | $ | 16,390,250 | ||||
Buildings and improvements | 70,182,308 | 101,878,107 | ||||||
Tenant improvements | 11,441,185 | 17,645,103 | ||||||
Lease intangibles | 1,400,602 | 3,467,798 | ||||||
| Real estate assets and lease intangibles held for investment, cost | 95,531,252 | 139,381,258 | ||||||
| Accumulated depreciation and amortization | (26,500,435 | ) | (37,536,809 | ) | ||||
| Real estate assets and lease intangibles held for investment, net | 69,030,817 | 101,844,449 | ||||||
| Real estate assets held for sale, net | 9,734,179 | 6,805,255 | ||||||
| Real estate assets, net | 78,764,996 | 108,649,704 | ||||||
Other assets: | ||||||||
Cash, cash equivalents and restricted cash | 2,501,703 | 7,422,359 | ||||||
Deferred leasing costs, net | 1,029,840 | 1,340,853 | ||||||
| 1,317,000 | 1,317,000 | |||||||
Investment in Conduit Pharmaceuticals marketable securities | 8,366 | 3,900 | ||||||
Deferred tax asset | 223,388 | 223,388 | ||||||
Other assets, net | 2,453,281 | 3,095,670 | ||||||
| Total other assets | 7,533,578 | 13,403,170 | ||||||
TOTAL ASSETS (1) | $ | 86,298,574 | $ | 122,052,874 | ||||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities: | ||||||||
| Mortgage notes payable, net | $ | 54,808,942 | $ | 81,936,586 | ||||
| Mortgage notes payable related to real estate assets held for sale, net | 7,029,816 | 10,137,781 | ||||||
Mortgage notes payable, total net | 61,838,758 | 92,074,367 | ||||||
| Accounts payable and accrued liabilities | 2,525,892 | 3,302,187 | ||||||
| Accrued real estate taxes | 1,289,512 | 1,785,029 | ||||||
| Dividends payable | - | 190,220 | ||||||
| Lease liability, net | 20,627 | 40,108 | ||||||
| Below-market leases, net | - | 3,316 | ||||||
Total liabilities | 65,674,789 | 97,395,227 | ||||||
| Commitments and contingencies | ||||||||
| Equity: | ||||||||
| Series D Preferred Stock, | 9,737 | 9,737 | ||||||
| Series A Common Stock, | 13,169 | 13,142 | ||||||
| Additional paid-in capital | 187,319,317 | 186,762,388 | ||||||
| Dividends and accumulated losses | (173,846,168 | ) | (169,945,302 | ) | ||||
Total stockholders' equity before noncontrolling interest | 13,496,055 | 16,839,965 | ||||||
| Noncontrolling interest | 7,127,730 | 7,817,682 | ||||||
Total equity | 20,623,785 | 24,657,647 | ||||||
TOTAL LIABILITIES AND EQUITY | $ | 86,298,574 | $ | 122,052,874 | ||||
(1) As of
Consolidated Statements of Operations
| For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
Revenues: | ||||||||||||||||
Rental income | $ | 2,939,487 | $ | 4,108,866 | $ | 10,379,899 | $ | 12,423,048 | ||||||||
Fees and other income | 40,586 | 87,276 | 188,049 | 277,018 | ||||||||||||
Total revenue | 2,980,073 | 4,196,142 | 10,567,948 | 12,700,066 | ||||||||||||
Costs and expenses: | ||||||||||||||||
Rental operating costs | 1,074,084 | 1,534,563 | 3,877,189 | 4,609,810 | ||||||||||||
General and administrative | 1,259,385 | 1,450,061 | 4,274,505 | 4,335,697 | ||||||||||||
Depreciation and amortization | 884,671 | 1,235,640 | 2,782,350 | 3,691,435 | ||||||||||||
Impairment of goodwill and real estate assets | 112,437 | 82,913 | 3,614,960 | 4,427,245 | ||||||||||||
Total costs and expenses | 3,330,577 | 4,303,177 | 14,549,004 | 17,064,187 | ||||||||||||
Other income (expense): | ||||||||||||||||
Interest expense - mortgage notes | (1,137,455 | ) | (1,499,075 | ) | (4,339,461 | ) | (4,487,415 | ) | ||||||||
Net gain (loss) in Conduit Pharmaceuticals marketable securities (see Note 9) | (3,261 | ) | (212 | ) | 4,467 | (184,672 | ) | |||||||||
Interest and other income, net | 5,258 | 5,263 | 15,613 | 15,618 | ||||||||||||
Gain (loss) on sales of real estate, net | (100,924 | ) | 300,975 | 49,175 | 5,078,302 | |||||||||||
Gain on disposition of assets and liabilities, net | - | - | 3,416,501 | - | ||||||||||||
Gain on extinguishment of debt | 1,007,432 | - | 1,007,432 | - | ||||||||||||
Income tax (expense) benefit | 54,217 | 14,871 | 9,530 | (13,630 | ) | |||||||||||
Total other income (expense), net | (174,733 | ) | (1,178,178 | ) | 163,257 | 408,203 | ||||||||||
Net loss | (525,237 | ) | (1,285,213 | ) | (3,817,799 | ) | (3,955,918 | ) | ||||||||
Less: (Income) loss attributable to noncontrolling interests | (5,412 | ) | (5,635 | ) | (83,067 | ) | (346,103 | ) | ||||||||
Net loss attributable to | $ | (530,649 | ) | $ | (1,290,848 | ) | $ | (3,900,866 | ) | $ | (4,302,021 | ) | ||||
Less: Series D Preferred Stock declared dividends | - | (571,179 | ) | - | (1,724,850 | ) | ||||||||||
Less: Series D Preferred Stock undeclared dividends in arrears | (570,541 | ) | - | (1,711,623 | ) | - | ||||||||||
Net loss attributable to | $ | (1,101,190 | ) | $ | (1,862,027 | ) | $ | (5,612,489 | ) | $ | (6,026,871 | ) | ||||
Net loss per share attributable to | ||||||||||||||||
Basic & Diluted | $ | (0.84 | ) | $ | (1.53 | ) | $ | (4.27 | ) | $ | (4.95 | ) | ||||
Weighted average number of common shares outstanding - basic & dilutive | 1,316,939 | 1,215,943 | 1,315,595 | 1,216,873 | ||||||||||||
FFO AND CORE FFO RECONCILIATION
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
Net (loss) income attributable to | $ | (1,101,190 | ) | $ | (1,862,027 | ) | $ | (5,612,489 | ) | $ | (6,026,871 | ) | ||||
Adjustments: | ||||||||||||||||
Income attributable to noncontrolling interests | 5,412 | 5,635 | 83,067 | 346,103 | ||||||||||||
Depreciation and amortization | 884,671 | 1,235,640 | 2,782,350 | 3,691,435 | ||||||||||||
Amortization of above and below market leases, net | (829 | ) | (1,244 | ) | (3,316 | ) | (3,509 | ) | ||||||||
Impairment of real estate assets | 112,437 | 82,913 | 3,614,960 | 4,427,245 | ||||||||||||
Loss on Conduit marketable securities | 3,261 | 212 | (4,467 | ) | 184,672 | |||||||||||
Gain (loss) on sale of real estate | 100,924 | (300,975 | ) | (49,175 | ) | (5,078,302 | ) | |||||||||
Gain on extinguishment of debt | $ | (1,007,432 | ) | - | (1,007,432 | ) | - | |||||||||
Loss on assets and liabilities transferred to lender in satisfaction of debt | - | - | (3,416,501 | ) | - | |||||||||||
FFO | (1,002,746 | ) | $ | (839,846 | ) | $ | (3,613,003 | ) | $ | (2,459,227 | ) | |||||
Stock Based Compensation | $ | 173,426 | 287,447 | 556,956 | 831,823 | |||||||||||
Core FFO | (829,320 | ) | $ | (552,399 | ) | $ | (3,056,047 | ) | $ | (1,627,404 | ) | |||||
Weighted average number of common shares outstanding - basic | 1,316,939 | 1,215,943 | 1,315,595 | 1,216,873 | ||||||||||||
Core FFO / Wgt Avg Share | $ | (0.63 | ) | $ | (0.45 | ) | $ | (2.32 | ) | $ | (1.34 | ) | ||||
Quarterly Dividends / Share | $ | - | $ | - | $ | - | $ | - | ||||||||
SOURCE:
View the original press release on ACCESS Newswire